Login / Signup

Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study.

Douglas B JohnsonAli ManouchehriAlexandra M HaughHenry T QuachJustin M BalkoBenedicte Lebrun-VignesAndrew MammenJavid J MoslehiJoe-Elie Salem
Published in: Journal for immunotherapy of cancer (2019)
ICIs produce a spectrum of distinct classes of neurologic AEs that can cause significant morbidity and mortality and tend to occur early and with class-specific associations.
Keyphrases
  • oxidative stress
  • adverse drug